The ramp-up to cold and flu season is a bad time for consumers to learn that some of their most trusted go-to products don't actually work.
retrieved 26 October 2023 from https://medicalxpress.com/news/2023-10-fda-conclusion-oral-phenylephrine-ineffective.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Sep 12, 2023Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves Zilbrysq for generalized myasthenia gravisThe U.S. Food and Drug Administration has approved UCB' Zilbrysq (zilucoplan) for the treatment of adults with generalized myasthenia gravis.
Read more »
FDA says getting Covid shot on same day as certain flu vaccines may raise risk of strokes in elderly...Two new analyses by the US FDA have flagged up possible health concerns about the Covid shots made by Pfizer and Moderna. But the agency stresses the links are not definitive.
Read more »
Researchers uncover mechanism for treating dangerous liver conditionA study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved medications.
Read more »
Researchers identify mechanism through which dietary omega 3 supplements alleviate liver conditionA study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved medications.
Read more »
NF-κB activation during COVID-19 and its impact on patients with hypertensionResearchers review the role of NF-κB activation in the replication of SARS-CoV-2 and the impact of COVID-19 medications on NF-κB activation.
Read more »
American power: indispensable or ineffective?How Joe Biden manages the war between Israel and Hamas will define America’s global role
Read more »